Biotech

All Articles

J &amp J falls phase 2 dengue prospect in latest change coming from injections

.Johnson &amp Johnson's deprioritization of its contagious illness pipe has asserted yet another suf...

Relay drops 10% of personnel after earlier discharges in July

.Precision medicine biotech Relay Therapies is actually shedding approximately 10% of its own staff ...

Pentixapharm ratings $22M IPO to loan radiopharma tests

.Pentixapharm has brought in almost 20 thousand euros ($ 22 million) coming from an IPO, along with ...

Lundbeck water faucets Charles River for AI-enabled neuro medicine finding

.Lundbeck has utilized Charles Stream Laboratories' artificial intelligence capacities to aid the in...

Big pharma, biotech 'will not automatically be actually cooperative' in AI: S&ampP

.Major Pharma is actually committing highly in artificial intelligence to reduce development timelin...

I &amp I biotech Triveni increases $115M for preclinical antibodies

.Triveni Bio has roped in $115 million in set B funds to advance preclinical antibody programs desig...

IGM turns coming from cancer cells to autoimmune, agitating C-suite

.IGM Biosciences finished in 2014 laying off workers and also improving its cancer pipe. Right now, ...

Shattuck centers CD47 course over weak efficacy data, gives up 40% of team as well as drops Ono handle

.Shattuck Labs has pounded another nail into the coffin of CD47. After seeing a "reasonable" result ...

BioMarin goes Backpacking, striking RNA deal with biotech

.BioMarin is incorporating firewood to the R&ampD fire, striking a complement along with CAMP4 Rehab...

Cash- strapped Gritstone starts search for tactical choices as cancer vaccination records underwhelm

.Gritstone bio has generated financiers to check out "potential value-maximizing approaches" after i...